Rosacea is a common skin condition that causes redness and visible blood vessels in the face.
In a review published in the British Journal of Dermatology, the researchers examined the prevalence of
rosacea among dermatology patients and in the general population worldwide by analyzing 32 studies including 41 populations and 26,538,319 individuals.
All these studies reported on topical
rosacea treatments and included the following polyphenols: silymarin from milk thistle; licochalcone from Chinese licorice; an extract from quassia; and flavonoids from Chrysanthellum indicum.
Researchers looked at close to 83,000 women from the Nurses' Health Study II and found that those who drank at least four cups of caffeinated coffee each day had a significantly lower risk of developing
rosacea than women who drank less than one cup of coffee per month.
The four subtypes of
rosacea should be used to classify lesions, not people, she said.
Bhatt et al.1 in their study on steroid-induced
rosacea showed maximum number of patients i.e.
Papulopustular
rosacea (subtype II) is characterized by the presence of erythematous, dome-shaped papules distributed in crops in the central facial region.
Signs of
rosacea include facial redness, bumps and pimples, eye irritation and swelling, burning or stinging skin, swelling/thickening of the skin, and the appearance of tiny blood vessels.
Stein Gold, who directs dermatology clinical trials at the Henry Ford Hospital in Detroit, shared new information about the pathophysiology of
rosacea and the controversial associations with cardiovascular disease and addressed the
rosacea "genes versus environment" etiology question.
Ocular manifestations have been reported in 3-58% of patients with
rosacea [9-11].